Top

CardioVascular and Interventional Radiology

Published in:

01-06-2015 | Clinical Investigation

Percutaneous Transhepatic Biliary Metal Stent for Malignant Hilar Obstruction: Results and Predictive Factors for Efficacy in 159 Patients from a Single Center

Authors: Mingwu Li, Ming Bai, Xingshun Qi, Kai Li, Zhanxin Yin, Jianhong Wang, Wenbing Wu, Luanluan Zhen, Chuangye He, Daiming Fan, Zhuoli Zhang, Guohong Han

Published in: CardioVascular and Interventional Radiology | Issue 3/2015

Abstract

Aim

To investigate and compare the efficacy and safety of percutaneous transhepatic biliary stenting (PTBS) using a one- or two-stage procedure and determine the predictive factors for the efficacious treatment of malignant hilar obstruction (MHO).

Methods

159 consecutive patients with MHO who underwent PTBS were enrolled between January 2010 and June 2013. Patients were classified into one- or two-stage groups. Independent predictors of therapeutic success were evaluated using a logistic regression model.

Results

108 patients were treated with one-stage PTBS and 51 patients were treated with two-stage PTBS. The stents were technically successful in all patients. Successful drainage was achieved in 114 patients (71.4 %). A total of 42 early major complications were observed. Re-interventions were attempted in 23 patients during follow-up. The cumulative primary patency rates at 3, 6, and 12 months were 88, 71, and 48 %, respectively. Stent placement using a one- or two-stage procedure did not significantly affect therapeutic success, early major complications, median stent patency, or survival. A stent placed across the duodenal papilla was an independent predictor of therapeutic success (odds ratio = 0.262, 95 % confidence interval [0.107–0.642]). Patients with stents across papilla had a lower rate of cholangitis compared with patients who had a stent above papilla (7.1 vs. 20.3 %, respectively, p = 0.03).

Conclusions

The majority of patients with MHO who underwent one-stage PTBS showed similar efficacy and safety outcomes compared with those who underwent two-stage PTBS. Stent placement across the duodenal papilla was associated with a higher therapeutic success rate.

Okuda K, Nakanuma Y, Miyazaki M (2002) Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepatol 17:1049–1055CrossRefPubMed

de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM (1999) Biliary tract cancers. N Engl J Med 341:1368–1378CrossRefPubMed

Aljiffry M, Walsh MJ, Molinari M (2009) Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990–2009. World J Gastroenterol 15:4240–4262CrossRefPubMedCentralPubMed

Cubertafond P, Mathonnet M, Gainant A, Launois B (1999) Radical surgery for gallbladder cancer. Results of the French Surgical Association Survey. Hepatogastroenterology 46:1567–1571PubMed

Valero VR, Cosgrove D, Herman JM, Pawlik TM (2012) Management of perihilar cholangiocarcinoma in the era of multimodal therapy. Expert Rev Gastroenterol Hepatol 6:481–495CrossRefPubMedCentralPubMed

Jarnagin WR, Ruo L, Little SA et al (2003) Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer 98:1689–1700CrossRefPubMed

Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T et al (2013) Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol 28:593–607CrossRefPubMed

Saluja SS, Gulati M, Garg PK et al (2008) Endoscopic or percutaneous biliary drainage for gallbladder cancer: a randomized trial and quality of life assessment. Clin Gastroenterol Hepatol 6:944–950CrossRefPubMed

Paik WH, Park YS, Hwang JH et al (2009) Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Gastrointest Endosc 69:55–62CrossRefPubMed

10.

Kang MJ, Choi YS, Jang JY, Han IW, Kim SW (2013) Catheter tract recurrence after percutaneous biliary drainage for hilar cholangiocarcinoma. World J Surg 37:437–442CrossRefPubMed

11.

Sangchan A, Kongkasame W, Pugkhem A, Jenwitheesuk K, Mairiang P (2012) Efficacy of metal and plastic stents in unresectable complex hilar cholangiocarcinoma: a randomized controlled trial. Gastrointest Endosc 76:93–99CrossRefPubMed

12.

Mukai T, Yasuda I, Nakashima M et al (2013) Metallic stents are more efficacious than plastic stents in unresectable malignant hilar biliary strictures: a randomized controlled trial. J Hepatobiliary Pancreat Sci 20:214–222CrossRefPubMed

13.

Yoshida H, Tajiri T, Mamada Y et al (2003) One-step insertion of an expandable metallic stent for unresectable common bile duct carcinoma. J Nippon Med Sch 70:179–182CrossRefPubMed

14.

Gwon DI, Ko GY, Kim JH et al (2013) Percutaneous bilateral metallic stent placement using a stentin-stent deployment technique in patients with malignant hilar biliary obstruction. AJR Am J Roentgenol 200:909–914CrossRefPubMed

15.

Bae JI, Park AW, Choi SJ et al (2008) Crisscross-configured dual stent placement for trisectoral drainage in patients with advanced biliary hilar malignancies. J Vasc Interv Radiol 19:1614–1619CrossRefPubMed

16.

Gwon DI, Ko GY, Yoon HK et al (2012) Safety and efficacy of percutaneous Y-configured covered stent placement for malignant hilar biliary obstruction: a prospective, pilot study. J Vasc Interv Radiol 23:528–534CrossRefPubMed

17.

Gwon DI, Ko GY, Sung KB et al (2011) Percutaneous biliary metallic stent placement in patients with unilobar portal vein occlusion caused by advanced hilar malignancy: outcome of unilateral versus bilateral stenting. AJR Am J Roentgenol 197:795–801CrossRefPubMed

18.

Kim CW, Park AW, Won JW, Kim S, Lee JW, Lee SH (2004) T-configured dual stent placement in malignant biliary hilar duct obstructions with a newly designed stent. J Vasc Interv Radiol 15:713–717CrossRefPubMed

19.

Ferro C, Perona F, Barile A et al (1994) Treatment of malignant occlusions of bile ducts by one-step technique using metallic endoprostheses. A multicenter study of 50 cases. Radiol Med 88:74–78PubMed

20.

Yoshida H, Mamada Y, Taniai N et al (2006) One-step palliative treatment method for obstructive jaundice caused by unresectable malignancies by percutaneous transhepatic insertion of an expandable metallic stent. World J Gastroenterol 12:2423–2426PubMedCentralPubMed

21.

Akamatsu N, Sugawara Y, Shin N et al (2011) One-step percutaneous transhepatic insertion of a balloon-expanding metallic stent for obstructive jaundice. J Gastroenterol Hepatol 26:1795–1803CrossRefPubMed

22.

Inal M, Aksungur E, Akgul E, Oguz M, Seydaoglu G (2003) Percutaneous placement of metallic stents in malignant biliary obstruction: one-stage or two-stage procedure? Pre-dilate or not? Cardiovasc Interv Radiol 26:40–45CrossRef

23.

Brountzos EN, Ptochis N, Panagiotou I, Malagari K, Tzavara C, Kelekis D (2007) A survival analysis of patients with malignant biliary strictures treated by percutaneous metallic stenting. Cardiovasc Intervent Radiol 30:66–73CrossRefPubMed

24.

Hatzidakis AA, Tsetis D, Chrysou E, Sanidas E, Petrakis J, Gourtsoyiannis NC (2001) Nitinol stents for palliative treatment of malignant obstructive jaundice: should we stent the sphincter of Oddi in every case? Cardiovasc Intervent Radiol 24:245–248CrossRefPubMed

25.

Cardella JF, Kundu S, Miller DL, Millward SF, Sacks D (2009) Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 20:S189–S191CrossRefPubMed

26.

Gandini R, Fabiano S, Pipitone V et al (2005) Management of biliary neoplastic obstruction with two different metallic stents implanted in one session. Cardiovasc Intervent Radiol 28:48–52CrossRefPubMed

27.

Dumonceau JM, Tringali A, Blero D et al (2012) Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy 44:277–298CrossRefPubMed

28.

Walter T, Ho CS, Horgan AM et al (2013) Endoscopic or percutaneous biliary drainage for Klatskin tumors? J Vasc Interv Radiol 24:113–121CrossRefPubMed

29.

Valle J, Wasan H, Palmer DH et al (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362:1273–1281CrossRefPubMed

30.

Lee SH, Park JK, Yoon WJ et al (2007) Optimal biliary drainage for inoperable Klatskin’s tumor based on Bismuth type. World J Gastroenterol 13:3948–3955CrossRefPubMedCentralPubMed

31.

Al-Bahrani AZ, Holt A, Hamade AM et al (2006) Acute pancreatitis: an under-recognized risk of percutaneous transhepatic distal biliary intervention. HPB (Oxford) 8:446–450CrossRef

32.

Savader SJ, Venbrux AC, Robbins KV, Gittelsohn AM, Osterman FA (1991) Pancreatic response to percutaneous biliary drainage: a prospective study. Radiology 178:343–346CrossRefPubMed

33.

Choi SH, Gwon DI, Ko GY et al (2011) Hepatic arterial injuries in 3110 patients following percutaneous transhepatic biliary drainage. Radiology 261:969–975CrossRefPubMed

34.

Kone BC, Watson AJ, Gimenez LF, Kadir S (1986) Acute renal failure following percutaneous transhepatic cholangiography. A retrospective study. Arch Intern Med 146:1405–1407CrossRefPubMed

35.

Gwon DI, Ko GY, Kim JH et al (2010) A comparative analysis of PTFE-covered and uncovered stents for palliative treatment of malignant extrahepatic biliary obstruction. AJR Am J Roentgenol 195:W463–W469CrossRefPubMed

36.

Almadi MA, Barkun AN, Martel M (2013) No benefit of covered vs uncovered self-expandable metal stents in patients with malignant distal biliary obstruction: a meta-analysis. Clin Gastroenterol Hepatol 11:27–37CrossRefPubMed

37.

Thornton RH, Ulrich R, Hsu M et al (2012) Outcomes of patients undergoing percutaneous biliary drainage to reduce bilirubin for administration of chemotherapy. J Vasc Interv Radiol 23:89–95CrossRefPubMed

Title: Percutaneous Transhepatic Biliary Metal Stent for Malignant Hilar Obstruction: Results and Predictive Factors for Efficacy in 159 Patients from a Single Center
Authors: Mingwu Li
Ming Bai
Xingshun Qi
Kai Li
Zhanxin Yin
Jianhong Wang
Wenbing Wu
Luanluan Zhen
Chuangye He
Daiming Fan
Zhuoli Zhang
Guohong Han
Publication date: 01-06-2015
Publisher: Springer US
Published in: CardioVascular and Interventional Radiology / Issue 3/2015
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-014-0992-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Percutaneous Transhepatic Biliary Metal Stent for Malignant Hilar Obstruction: Results and Predictive Factors for Efficacy in 159 Patients from a Single Center

Abstract

Aim

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Aim

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2015

Percutaneous Irreversible Electroporation of Locally Advanced Pancreatic Carcinoma Using the Dorsal Approach: A Case Report

Long-term Outcome of Peripherally Implanted Venous Access Ports in the Forearm in Female Cancer Patients

Thromboembolic Complications after Zenith® Low Profile Endovascular Graft for Infrarenal Abdominal Aneurysms

The Use of ExoSeal Vascular Closure Device for Direct Antegrade Superficial Femoral Artery Puncture Site Hemostasis

Type 2 Endoleaks Post-EVAR: Current Evidence for Rupture Risk, Intervention and Outcomes of Treatment

Prophylactic Embolization of the Cystic Artery Prior to Radioembolization of Liver Malignancies—An Evaluation of Necessity